Munir Shahjahan

Once-daily intravenous busulfan and fludarabine: clinical and pharmacokinetic results of a myeloablative, reduced-toxicity conditioning regimen for allogeneic stem cell transplantation in AML and MDS

Marcos de Lima, Daniel R. Couriel, Peter F. Thall et al. · Blood · 2004 · 422 citations

Pharmacy, Pharmacokinetics, Pharmacology +17

Nonablative versus reduced-intensity conditioning regimens in the treatment of acute myeloid leukemia and high-risk myelodysplastic syndrome: dose is relevant for long-term disease control after allogeneic hematopoietic stem cell transplantation

Marcos de Lima, Mark F. Munsell, Munir Shahjahan et al. · Blood · 2004 · 373 citations · Full text

Medicine, Hematology, Oncology +16

Hematopoietic cell transplantation–specific comorbidity index as an outcome predictor for patients with acute myeloid leukemia in first remission: combined FHCRC and MDACC experiences

Mohamed L. Sorror, Sergio Giralt, Brenda M. Sandmaier et al. · Blood · 2007 · 327 citations · Full text

Medicine, Hematology, Oncology +9

Reduced-intensity conditioning for unrelated donor hematopoietic stem cell transplantation as treatment for myeloid malignancies in patients older than 55 years

Raymond Wong, Sergio Giralt, Thomas G. Martin et al. · Blood · 2003 · 171 citations

Medicine, Hematology, Oncology +14

Prognostic factors for outcomes of patients with refractory or relapsed acute myelogenous leukemia or myelodysplastic syndromes undergoing allogeneic progenitor cell transplantation

Raymond Wong, Munir Shahjahan, Xuemei Wang et al. · Biology of Blood and Marrow Transplantation · 2005 · 117 citations · Full text

Medicine, Hematology, Oncology +17